|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 487/16 | |
| C07D 498/16 | |||
| A61P 31/18 | |||
| A61K 31/4985 | |||
| A61K 31/5365 | |||
| A61K 31/424 |
| (11) | Patento numeris | 3548493 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17817547.7 |
| Europos patento paraiškos padavimo data | 2017-11-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-10-09 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-11-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/063831 |
| Data | 2017-11-30 |
| (87) | Numeris | WO 2018/102485 |
| Data | 2018-06-07 |
| (30) | Numeris | Data | Šalis |
| 201662429470 P | 2016-12-02 | US |
| (72) |
GRAHAM, Thomas, H., US
YU, Tao, US
ZHANG, Yonglian, US
MCCAULEY, John, A., US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | TETRACYCLIC HETEROCYCLE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS |
| TETRACYCLIC HETEROCYCLE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS |